AstraZeneca competitorsClear all
Daiichi Sankyo's top competitors include Novartis, Amgen, Bayer and Teva Pharmaceuticals.
 Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. |  Amgen Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products. | ||||
Founding Date | Founding Date 2005 | Founding Date 1996 | Founding Date 1980 | Founding Date 1863 | Founding Date 1901 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Tokyo, JP HQ Wien, AT Braine L'alleud, BE Sao Paulo, BR São Paulo, BR Beijing, CN Shanghai, CN see more | Locations Thousand Oaks, US HQ Hydra, DZ Vicente López, AR Sydney, AU Wien, AT Machelen, BE Santo Amaro, BR see more | Locations Petah Tikva, IL HQ Villa Adelina, AR Macquarie Park, AU Minsk, BY Antwerpen, BE São Paulo, BR Dupnica, BG see more | ||
Employees | Employees 16,0334% increase | Employees 110,0004% increase | Employees 24,200 | Employees 99,6372% decrease | Employees 37,100 |
Valuation ($) | Valuation ($) 44.4 b | Valuation ($) N/A | Valuation ($) 137.9 b | Valuation ($) 65.3 b | Valuation ($) N/A |
Twitter followers | Twitter followers 624 | Twitter followers 299.9 k | Twitter followers 105.3 k | Twitter followers 183 k | Twitter followers 3.6 k |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 26 | Number of tweets (last 30 days) 136 | Number of tweets (last 30 days) 66 | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 13.3 | Average likes per tweet (last 30 days) 5.9 | Average likes per tweet (last 30 days) 19.1 | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 50% | Percentage of tweets with engagement (last 30 days) 95.59% | Percentage of tweets with engagement (last 30 days) 62.12% | Percentage of tweets with engagement (last 30 days) N/A |
Alexa Website Rank | Alexa Website Rank 560867 | Alexa Website Rank 102511 | Alexa Website Rank 181163 | Alexa Website Rank 77182 | Alexa Website Rank 338084 |
Employee Rating | Employee Rating 3.9 | Employee Rating 4.2 | Employee Rating 4.1 | Employee Rating 4.3 | Employee Rating 3.6 |
Financial | |||||
Revenue (est.) | Revenue (est.) ¥962.5b (FY, 2021) | Revenue (est.) $52.9b (FY, 2021) | Revenue (est.) $26b (FY, 2021) | Revenue (est.) €44.1b (FY, 2021) | Revenue (est.) $16.7b (FY, 2020) |
Cost of goods | Cost of goods (¥280.9b) (FY, 2021) | Cost of goods ($9.7b) (FY, 2021) | Cost of goods $6.5b (FY, 2021) | Cost of goods (€11.7b) (FY, 2021) | Cost of goods $8.9b (FY, 2020) |
Gross profit | Gross profit ¥681.6b (FY, 2021) | Gross profit $45.1b (FY, 2021) | Gross profit $19.5b (FY, 2021) | Gross profit €33.6b (FY, 2021) | Gross profit $7.7b (FY, 2020) |
Net income | Net income ¥75.8b (FY, 2021) | Net income $24b (FY, 2021) | Net income $5.9b (FY, 2021) | Net income €1b (FY, 2021) | Net income ($4.1b) (FY, 2020) |
Operating ⚠ | |||||
Countries | Countries N/A | Countries N/A | Countries 100 (FY, 2020) | Countries 153 (FY, 2018) | Countries N/A |
Facilities | Facilities N/A | Facilities N/A | Facilities 180 (FY, 2020) | Facilities N/A | Facilities 90 (FY, 2019) |
Patent Applications | Patent Applications 415 (Dec, 2020) | Patent Applications N/A | Patent Applications N/A | Patent Applications 48.1 k (FY, 2017) | Patent Applications N/A |
Phase I Trials Products | Phase I Trials Products 16 (FY, 2019) | Phase I Trials Products N/A | Phase I Trials Products 20 (FY, 2020) | Phase I Trials Products N/A | Phase I Trials Products N/A |
Phase II Trials Products | Phase II Trials Products 7 (FY, 2019) | Phase II Trials Products N/A | Phase II Trials Products 5 (FY, 2020) | Phase II Trials Products 12 (Jan, 2020) | Phase II Trials Products N/A |
Phase III Trials Products | Phase III Trials Products 7 (FY, 2019) | Phase III Trials Products 54 (FY, 2021) | Phase III Trials Products 11 (FY, 2020) | Phase III Trials Products 9 (Jan, 2020) | Phase III Trials Products N/A |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 6.5m | Total funding raised N/A | Total funding raised $ 3.5b | Total funding raised $ 358m |
For sources of this data, please see the company profile
View company profiles
Novartis
HQ
Basel, CH
Employees
110,000↑ 4% increase
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View companyAmgen
HQ
Thousand Oaks, US
Employees
24,200
Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products.
View company
Bayer
HQ
Leverkusen, DE
Employees
99,637↓ 2% decrease
Bayer is a global life science company specializing in healthcare and nutrition.
View company
Teva Pharmaceuticals
HQ
Petah Tikva, IL
Employees
37,100
Teva Pharmaceuticals is a global pharmaceutical company.
View company